Agenda

8:00-9:00am       

Registration and Continental Breakfast

9:00 am       

Welcoming Remarks       

• Mark Leahey, President and CEO, MDMA

9:05 – 9:45 am

Attracting Funding and Deal Design

• Brad Vale, PhD, DVM, Vice President, Head of Venture Investments, Johnson & Johnson Development Corporation
• J. Casey McGlynn, Partner and Chairman Life Sciences Group, Wilson Sonsini Goodrich & Rosati
• Kevin Wasserstein, Managing Director, Versant Ventures 

9:45-10:15 am       

Implementation of the Health Care Law 

• Mark Leahey, President and CEO, MDMA

10:15 – 10:30 am   

Networking Break

10:30-11:15 am   

Keynote Address: Food and Drug Administration

• Joshua Sharfstein, M.D., Principal Deputy Commissioner, FDA, HHS 

11:15-12:15 pm  

Reaction Panel: Understanding the Changing Landscape at FDA

• Josh Makower M.D., Founder and CEO, ExploraMed Development
• David M. Hoffmeister, Partner, Wilson Sonsini Goodrich & Rosati
• Marti Conger, Patient Advocate

12:15 – 1:15 pm   

Networking Luncheon

1:15-2:15 pm       

Reimbursement Challenges for Entrepreneurial Companies
In recent years, companies with innovative medical therapies have faced numerous challenges in coding, coverage and payment.  The panel will discuss these challenges from the perspectives of a small business.

• Michael Beebe, Reimbursement Practice Leader, HillCo HEALTH
• Thomas Novelli, Vice President of Government Relations, MDMA

2:15 – 3:15 pm        

Impacting the Policy Debate in Washington

• Brendan Benner, Director of Public Policy, MDMA
• Mark Deem, Chief Technology Officer, The Foundry, LLC
• Eamonn Hobbs, MDMA Chairman, President & CEO, DelCath Systems, Inc.

3:15-4:00 pm       

Key Compliance Trends

• E. Elizabeth Halpern, Attorney, Hogan Lovells US LLP

4:00-5:30 pm       

Networking Reception
Meeting attendees will have the chance to compare notes and discuss the topics addressed throughout the day. Sponsored by WSGR